PETS icon

PetMed Express

4.97 USD
-0.13
2.55%
At close Dec 20, 4:00 PM EST
After hours
4.87
-0.10
2.01%
1 day
-2.55%
5 days
-10.13%
1 month
8.52%
3 months
42.00%
6 months
10.44%
Year to date
-34.43%
1 year
-32.20%
5 years
-78.89%
10 years
-64.60%
 

About: PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Employees: 287

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

14.25% less ownership

Funds ownership: 60.04% [Q2] → 45.79% (-14.25%) [Q3]

17% less call options, than puts

Call options by funds: $493K | Put options by funds: $597K

21% less funds holding

Funds holding: 116 [Q2] → 92 (-24) [Q3]

31% less capital invested

Capital invested by funds: $50.1M [Q2] → $34.7M (-$15.4M) [Q3]

71% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 34

74% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 53

Research analyst outlook

We haven’t received any recent analyst ratings for PETS.

Financial journalist opinion

Positive
Zacks Investment Research
2 weeks ago
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
Neutral
GlobeNewsWire
2 weeks ago
PetMeds® Adopts Limited Duration Shareholder Rights Plan
DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) (“PetMeds” or the “Company”), today announced that its Board of Directors (the “Board”) has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the “Rights Plan”).
PetMeds® Adopts Limited Duration Shareholder Rights Plan
Positive
Zacks Investment Research
1 month ago
Here's Why PetMed (PETS) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why PetMed (PETS) is a Strong Momentum Stock
Neutral
Business Wire
1 month ago
PetMeds Migrates to Ordergroove as its New Subscription and Membership Technology Partner
NEW YORK--(BUSINESS WIRE)--Ordergroove, the leading technology platform that powers subscriptions for top brands and retailers, today announced a strategic partnership with PetMed Express, Inc. (NASDAQ: PETS), the original online pet pharmacy dedicated to supporting the health and well-being of four-legged family members. This collaboration marks a significant step in modernizing and scaling PetMeds + PetCareRx's (PETS) subscription and membership capabilities to maximize operational efficiency.
PetMeds Migrates to Ordergroove as its New Subscription and Membership Technology Partner
Positive
Seeking Alpha
1 month ago
PetMed Express: Why (And Why Not) The Rebound Could Continue
PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release. Despite the massive post-earnings surge, further upside may lie ahead, if the turnaround continues. PetMed's management team is implementing a strategy change, not just cost-cutting measures, to continue improving the company's fiscal performance.
PetMed Express: Why (And Why Not) The Rebound Could Continue
Neutral
Seeking Alpha
1 month ago
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
PetMed (PETS) Surpasses Q2 Earnings Estimates
PetMed (PETS) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to break-even earnings per share a year ago.
PetMed (PETS) Surpasses Q2 Earnings Estimates
Neutral
GlobeNewsWire
1 month ago
PetMeds® Announces Second Quarter Fiscal 2025 Financial Results
DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its second quarter ended September 30, 2024.
PetMeds® Announces Second Quarter Fiscal 2025 Financial Results
Positive
Zacks Investment Research
1 month ago
4 Retail Stocks to Buy as Further Rate Cuts Loom
Casey's, PetMed, Alibaba and Deckers Outdoor are four retail stocks that should do well in the coming months as the Fed finally initiates rate cuts.
4 Retail Stocks to Buy as Further Rate Cuts Loom
Positive
Zacks Investment Research
2 months ago
Here's Why PetMed (PETS) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why PetMed (PETS) is a Strong Momentum Stock
Charts implemented using Lightweight Charts™